Rare Earth Meets Regenerative Medicine: Cerium-Vanadium Coatings Could Help Magnesium Implants Last Longer Inside the Human Body

May 13, 2026

3 minute read.

Highlights

  • Hybrid cerium-vanadium conversion coating with hydroxyapatite increased corrosion resistance of AZ31 magnesium alloy implants by approximately 50-fold while suppressing hydrogen evolution and maintaining antibacterial activity against S. aureus and E. coli.
  • The CeVCC+HA coating system improved surface stability, promoted uniform calcium-phosphate mineralization, and demonstrated superior coating integrity compared to single-element cerium or vanadium coatings alone.
  • This research expands rare earth applications beyond magnets and EVs into biomedical engineering, though long-term toxicity, immune response, and regulatory feasibility remain unresolved for clinical translation.

Researchers led by Negin Nojoomi and Hossein Eivaz Mohammadloo at the Iran Polymer and Petrochemical Institute, working with collaborators from Oregon State University and Amirkabir University of Technology, report that combining rare-earth cerium and transition-metal vanadium conversion coatings with hydroxyapatite significantly improved the corrosion resistance, bioactivity, and antibacterial performance of AZ31 magnesium alloy implants in simulated body-fluid experiments. The hybrid “CeVCC+HA” coating reduced magnesium degradation, lowered hydrogen evolution, improved surface stability, promoted more uniform calcium-phosphate mineralization, and maintained antibacterial activity against both Staphylococcus aureus and E. coli. The findings are important because magnesium-based implants are attractive for regenerative medicine but often corrode too rapidly inside the body to remain structurally reliable during healing.  

Engineering Around Magnesium’s Biggest Weakness

Magnesium alloys have long attracted interest for orthopedic implants because they are lightweight, biodegradable, and mechanically closer to natural bone than titanium or stainless steel. But they suffer from one major problem: rapid corrosion in physiological environments.

To address that weakness, the researchers tested several coating strategies on AZ31 magnesium alloy:

  • cerium-only conversion coatings,
  • vanadium-only coatings,
  • mixed cerium-vanadium conversion layers,
  • and a hybrid coating capped with hydroxyapatite (HA), a calcium-phosphate biomaterial widely used to support bone integration.

The team used electrochemical impedance spectroscopy, hydrogen-evolution monitoring, SEM imaging, wettability analysis, FTIR spectroscopy, and antibacterial testing to evaluate how the coatings behaved in simulated body fluid over prolonged immersion periods.

The Hybrid Coating Emerged as the Clear Winner

The standout performer was the CeVCC+HA hybrid system.

According to the electrochemical data, the hybrid coating produced approximately a 50-fold increase in corrosion resistance relative to untreated magnesium while significantly suppressing hydrogen evolution, a key indicator of magnesium degradation. SEM analysis also showed improved coating integrity, reduced crack propagation, and more uniform hydroxyapatite growth. Meanwhile, the cerium-vanadium layer itself demonstrated the strongest antibacterial performance, suggesting the hybrid architecture may balance both bioactivity and infection resistance.

The study also reinforces the growing scientific interest in cerium-based biomedical coatings, which may offer corrosion inhibition, partial self-healing, and oxidative antibacterial effects.

Important Limitations Remain

This remains an early-stage laboratory study conducted in simulated body fluid rather than in living organisms. Long-term toxicity, immune-system response, mechanical durability under physiological loading, manufacturability, and regulatory feasibility remain unresolved. Questions surrounding vanadium exposure and the aluminum content of AZ31 magnesium alloys also warrant further investigation despite prior reassuring in vivo studies cited by the authors.

Why This Matters

For Rare Earth Exchanges™ readers, the paper highlights a frequently overlooked reality: rare earth elements are steadily expanding beyond magnets, EVs, and defense systems into advanced biomedical engineering, regenerative medicine, corrosion science, and next-generation implant technologies.

Citation: Nojoomi N., Nikpayam M., Heydarinasab H. et al. Synergistic effect of rare-earth and transition metal conversion coatings on bioactive hydroxyapatite mineralization and electrochemical behavior of AZ31 magnesium alloys. Scientific Reports (2026).

Spread the word:

Search

Recent REEx News

Brazil Votes October 4 as Critical Minerals Law Meets Rare Earth Refining's Long Timetable

Department of War Targets Advanced Manufacturing to Rebuild U.S. Defense Production - Critical Materials Remain the Constraint

RAND Evaluates U.S. Critical-Minerals Policies ? Finds Stockpiles Fastest, Tax Credits Industry Favorite

Chalmers University Study Maps Gallium and Germanium Recycling Potential for Automotive Electronics

Rare-Earth Metallization: The Missing Middle in the Magnet Supply Chain

By Daniel

Inspired to launch Rare Earth Exchanges in part due to his lifelong passion for geology and mineralogy, and patriotism, to ensure America and free market economies develop their own rare earth and critical mineral supply chains.

0 Comments

No replies yet

Loading new replies...

D
DOC

Moderator

5,909 messages 103 likes

Cerium vanadium coating with hydroxyapatite boosts corrosion resistance and bioactivity of magnesium implants by 50-fold in lab tests. (read full article...)

Reply Like

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.